Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Schmidt
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
Cyrus Bio is a computationally-driven discovery company focused on naturally existing proteins that show the potential to be turned into…
Endogene.bio generates high-resolution data from menstrual blood to accelerate disease understanding, patient stratification, and…
TurbineVenture round $121M · 17 mo ago • 201-500 employees • 3 roles
Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
insitroVenture round $143M · 6 yr ago • Founded 2018 • 51-200 employees • 13 roles
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets…
Atomic1 role
Oriented at the cutting edge of AI, RNA and structural biology Atomic AI operates at the intersection of revolutionary breakthroughs in…

Overview

Decode ProteinInteractions 10× Faster. Bionsight combines cutting-edge chemoproteomics with artificial intelligence to identify therapeutic targets with unprecedented precision, accelerating drug discovery from years to months.